PARD OTC
Poniard Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-16M
Net Income
+57.8% YoY
$-10M
Free Cash Flow
+62.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-210.4%
ROA-82.5%
ROIC-442.5%
Valuation
P/E-0.0
P/B0.0
EV/EBITDA-0.5
Leverage
Debt/Equity0.53
Current Ratio0.76
Interest Cov.-29.0x
Quality Scores
Piotroski F3/9
Altman Z-87.20
Beneish M0.00